Novel glucagon-like peptide-1 drugs designed for type 2 diabetes

Novel glucagon-like peptide-1 (GLP-1) drugs were designed and industrially prepared by researchers at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences through molecular design, strain construction, ...

page 14 from 26